RIKER LAUREN 4

What Happened

• Lauren Riker, Senior Vice President, Finance at Pacira BioSciences (PCRX), was granted 19,273 restricted stock units (RSUs) on February 11, 2026. The grant was reported as an award/acquisition at $0.00, so no cash was paid; reported transaction value is $0. Each RSU represents the contingent right to receive one share of common stock upon vesting.

Key Details

• Transaction date: 2026-02-11; Form 4 filed: 2026-02-13 (timely filing).
• Transaction type/code: Award/Grant (A).
• Amount: 19,273 RSUs granted; price reported $0.00; total reported consideration $0.
• Vesting: RSUs vest in four equal annual installments beginning February 15, 2027, subject to continued service (per footnote).
• Shares owned after transaction: Not specified in the provided excerpt of the filing.
• No sale, exercise, or 10b5-1 plan noted in this grant disclosure.

Context

• RSU grants are a form of compensation and do not require an immediate cash outlay by the insider; they convert to stock only if and when they vest. Such awards are routine for employee retention and incentive and should not be interpreted alone as a buy or sell signal.